DexCom, Inc. (DXCM): A Bull Case Theory
We came across a bullish thesis on DexCom, Inc. on Flyover Stocks Substack by Todd Wenning. In this article, we will summarize the bulls’ thesis on DXCM.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 3,822,085 | $333,629,802 | +261% | 0.38% |
| 2. | 236,063,000 | $232,007,079 | +79% | 0.79% | |
| 3. | D E Shaw D. E. Shaw | 1,961,590 | $171,227,191 | -37% | 0.12% |
| 4. | Citadel Investment Group Ken Griffin | 1,368,728 | $119,476,267 | -36% | 0.02% |
| 5. | 90,500,000 | $88,948,618 | -7% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.01 | 25,000 | $1,250,250.00 | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | $496,100.00 | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | $1,085,000.00 | 121,975 | 2013-03-11 | Filing | |
| $10.37 | 1,000 | $10,369.00 | 6,000 | 2012-03-08 | Filing | |
| $10.34 | 1,000 | $10,340.00 | 5,000 | 2012-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $80.86 | 667 | $53,933.62 | 22,667 | 2025-09-05 | Filing | |
| $80.00 | 1,466 | $117,280.00 | 105,223 | 2025-09-04 | Filing | |
| $74.17 | 4,824 | $357,796.08 | 118,657 | 2025-09-02 | Filing | |
| $80.29 | 500 | $40,145.00 | 94,102 | 2025-08-15 | Filing | |
| $81.54 | 195 | $15,900.30 | 51,121 | 2025-08-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 48,322,405 | $4,218,062,732 | 0.07% | |
| 2. | 39,032,096 | $3,407,111,662 | 0.06% | |
| 3. | 16,858,078 | $1,471,541,629 | 0.06% | |
| 4. | 16,705,195 | $1,458,196,471 | 1.09% | |
| 5. | 11,517,546 | $1,005,366,575 | 0.6% |
News See All
10 Best NASDAQ Stocks with Huge Upside Potential
Warren Pies expressed cautious optimism, noting a bullish stance on the market with a price target of 6800 for the S&P 500.
Argus Initiates Coverage of DexCom (DXCM) with a Buy Rating
The firm told investors in a research note that it sees DexCom, Inc.
10 Best Strong Buy Growth Stocks to Buy Now
On August 27, Komal Sri-Kumar, Sri-Kumar Global Strategies president, appeared on CNBC’s ‘Squawk Box’ to talk about the fallout from President Trump’s firing of Fed Governor Lisa Cook, the effects...
DexCom (DXCM) Extends Losses on Day 5 Amid Leadership Change
DexCom fell for a fifth straight day on Monday, shedding 3.82 percent to close at $76.25 apiece as investors turned cautious following the announcement of a leadership change after the company’s strong...
DexCom, Inc. (NASDAQ:DXCM) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, welcome to the DexCom Second Quarter 2025 Earnings Release Conference Call. My name is Abby, and I'll be your conference operator today.
Mizuho Lifts PT on DexCom (DXCM) to $100 From $95, Keeps an Outperform Rating
DexCom, Inc. (NASDAQ:DXCM) is one of the best strong buy healthcare stocks to buy now. On July 16, Mizuho analyst Anthony Petrone raised the firm’s price target on DexCom, Inc.
10 Best Strong Buy Healthcare Stocks to Buy Now
On July 21, Jared Holz, Mizuho health care sector strategist, appeared on CNBC's 'The Exchange' to talk about whether any opportunity plays exist within the healthcare sector, and what pains the sector...
Oppenheimer Reaffirms DexCom Buy Rating Amid HHS Wearables Push
DexCom, Inc. (NASDAQ:DXCM) ranks among the best fundamental stocks to buy according to hedge funds. Oppenheimer reaffirmed its $95 price target and Outperform rating for DexCom, Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
